A First-in-Human Study of HP-002 for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Clinical trial NCT07658352 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07658352
- Sponsor
- Shanghai Helioson Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-26
- Primary completion
- 2029-06-26
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.